Oppenheimer lowered the firm’s price target on ESAB (ESAB) to $142 from $144 and keeps an Outperform rating on the shares. The firm notes shares dropped a confounding 17.2% after ESAB reported Q2 adjusted EPS of $1.36 vs. its/consensus $1.33/1.36 and raised 2025 guidance ranges. Although the market clearly expected more from the print, Oppenheimer believes tariff-related Americas headwinds are transient and is encouraged by ESAB’s continued HGM outgrowth, stepped-up innovation, and flexibility for strategic/accretive capital deployment going forward. Given ESAB’s strong foundation for flywheel value creation and Wednesday’s sizable pullback, the firm sees current valuation as notably supportive.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ESAB:
